Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism

Autism is a behaviorally defined neurodevelopmental disorder usually diagnosed in early childhood that is characterized by impairment in reciprocal communication and speech, repetitive behaviors, and social withdrawal. Although both genetic and environmental factors are thought to be involved, none have been reproducibly identified. The metabolic phenotype of an individual reflects the influence of endogenous and exogenous factors on genotype. As such, it provides a window through which the interactive impact of genes and environment may be viewed and relevant susceptibility factors identified. Although abnormal methionine metabolism has been associated with other neurologic disorders, these pathways and related polymorphisms have not been evaluated in autistic children. Plasma levels of metabolites in methionine transmethylation and transsulfuration pathways were measured in 80 autistic and 73 control children. In addition, common polymorphic variants known to modulate these metabolic pathways were evaluated in 360 autistic children and 205 controls. The metabolic results indicated that plasma methionine and the ratio of S‐adenosylmethionine (SAM) to S‐adenosylhomocysteine (SAH), an indicator of methylation capacity, were significantly decreased in the autistic children relative to age‐matched controls. In addition, plasma levels of cysteine, glutathione, and the ratio of reduced to oxidized glutathione, an indication of antioxidant capacity and redox homeostasis, were significantly decreased. Differences in allele frequency and/or significant gene–gene interactions were found for relevant genes encoding the reduced folate carrier (RFC 80G > A), transcobalamin II (TCN2 776G > C), catechol‐O‐methyltransferase (COMT 472G > A), methylenetetrahydrofolate reductase (MTHFR 677C > T and 1298A > C), and glutathione‐S‐transferase (GST M1). We propose that an increased vulnerability to oxidative stress (endogenous or environmental) may contribute to the development and clinical manifestations of autism. © 2006 Wiley‐Liss, Inc.

[1]  Flavio Keller,et al.  The neurobiological context of autism , 2003, Molecular Neurobiology.

[2]  M. Caudill,et al.  The glycine N-methyltransferase (GNMT) 1289 C->T variant influences plasma total homocysteine concentrations in young women after restricting folate intake. , 2005, The Journal of nutrition.

[3]  Mark Lucock,et al.  G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism. , 2005, Life sciences.

[4]  S. Milstien,et al.  Cerebrospinal fluid and serum markers of inflammation in autism. , 2005, Pediatric neurology.

[5]  E. Obberghen,et al.  Association of MTRR A66G polymorphism (but not of MTHFR C677T and A1298C, MTR A2756G, TCN C776G) with homocysteine and coronary artery disease in the French population , 2005, Thrombosis and Haemostasis.

[6]  George Perry,et al.  Oxidative Stress and Neurodegeneration , 2005, Annals of the New York Academy of Sciences.

[7]  Kristina M von Castel-Dunwoody,et al.  Transcobalamin 776C->G polymorphism negatively affects vitamin B-12 metabolism. , 2005, The American journal of clinical nutrition.

[8]  M. Egan,et al.  Effect of Catechol-O-Methyltransferase val158met Genotype on Attentional Control , 2005, The Journal of Neuroscience.

[9]  H. Jyonouchi,et al.  Dysregulated Innate Immune Responses in Young Children with Autism Spectrum Disorders: Their Relationship to Gastrointestinal Symptoms and Dietary Intervention , 2005, Neuropsychobiology.

[10]  M. Cleves,et al.  Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. , 2005, The American journal of clinical nutrition.

[11]  R. Banerjee,et al.  Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein. , 2005, Archives of biochemistry and biophysics.

[12]  David W Gaylor,et al.  Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.

[13]  M. Egan,et al.  Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.

[14]  W. Brown,et al.  Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. , 2004, Life sciences.

[15]  Alan Hubbard,et al.  Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. , 2004, Blood.

[16]  P. Stover.  Physiology of folate and vitamin B12 in health and disease. , 2004, Nutrition reviews.

[17]  S. Zoroglu,et al.  Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism , 2004, European Archives of Psychiatry and Clinical Neuroscience.

[18]  M. Pearce,et al.  Gene–gene interaction in folate-related genes and risk of neural tube defects in a UK population , 2004, Journal of Medical Genetics.

[19]  A. Diamond,et al.  Genetic and neurochemical modulation of prefrontal cognitive functions in children. , 2004, The American journal of psychiatry.

[20]  T. Kemper,et al.  The neuropathology of the autism spectrum disorders: what have we learned? , 2008, Novartis Foundation symposium.

[21]  F. Zitman,et al.  Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia , 2003, Psychiatry Research.

[22]  S. J. James,et al.  Increased plasma homocysteine and S-adenosylhomocysteine and decreased methionine is associated with altered phosphatidylcholine and phosphatidylethanolamine in cystic fibrosis. , 2003, The Journal of pediatrics.

[23]  J. Selhub,et al.  Combined marginal folate and riboflavin status affect homocysteine methylation in cultured immortalized lymphocytes from persons homozygous for the MTHFR C677T mutation. , 2003, The Journal of nutrition.

[24]  E. Bertini,et al.  Analysis of glutathione: implication in redox and detoxification. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[25]  K. Blennow,et al.  The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease. , 2003, Clinical chemistry.

[26]  J. F. White,et al.  Intestinal Pathophysiology in Autism , 2003, Experimental biology and medicine.

[27]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[28]  M. Mattson,et al.  Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders , 2003, Trends in Neurosciences.

[29]  R. Finnell,et al.  Reduced folate carrier polymorphism (80A→G) and neural tube defects , 2003, European Journal of Human Genetics.

[30]  H. Tager-Flusberg,et al.  Identifying neurocognitive phenotypes in autism. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[31]  Alan L. Miller,et al.  The methionine-homocysteine cycle and its effects on cognitive diseases. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[32]  P. Bosco,et al.  Genetic Determinants of Folate and Vitamin B12 Metabolism: A Common Pathway in Neural Tube Defect and Down Syndrome? , 2003, Clinical chemistry and laboratory medicine.

[33]  H. Forman,et al.  Cytoprotection against Oxidative Stress and the Regulation of Glutathione Synthesis , 2003, Biological chemistry.

[34]  H. Blom,et al.  Genetics of hyperhomocysteinaemia in cardiovascular disease , 2003, Annals of clinical biochemistry.

[35]  Inge-Marie Eigsti,et al.  A systems neuroscience approach to autism: biological, cognitive, and clinical perspectives. , 2003, Mental retardation and developmental disabilities research reviews.

[36]  H. Forman,et al.  Glutathione in Defense and Signaling , 2002 .

[37]  O. Yorbik,et al.  Investigation of antioxidant enzymes in children with autistic disorder. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[38]  Karoly Horvath,et al.  Autistic disorder and gastrointestinal disease , 2002, Current opinion in pediatrics.

[39]  H. Cordell.  Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. , 2002, Human molecular genetics.

[40]  Y. Shoenfeld,et al.  Brief Report: Immune Factors in Autism: A Critical Review , 2002, Journal of autism and developmental disorders.

[41]  Joshua W. Miller,et al.  Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults. , 2002, Blood.

[42]  Peter Szatmari,et al.  A risk-factor model of epistatic interaction, focusing on autism. , 2002, American journal of medical genetics.

[43]  H. Blom,et al.  Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects , 2002, European Journal of Human Genetics.

[44]  A. Nieoullon.  Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.

[45]  M. Mora,et al.  Antioxidant and Pro-oxidant Effect of the Thiolic Compounds N -acetyl- l -cysteine and Glutathione against Free Radical-induced Lipid Peroxidation , 2002, Free radical research.

[46]  Shelly C. Lu,et al.  S‐Adenosylmethionine: a control switch that regulates liver function , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  B. Deplancke,et al.  Redox control of the transsulfuration and glutathione biosynthesis pathways. , 2002, Current opinion in clinical nutrition and metabolic care.

[48]  H. Forman,et al.  Glutathione in defense and signaling: lessons from a small thiol. , 2002, Annals of the New York Academy of Sciences.

[49]  J. Parry,et al.  Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. , 2002, Teratogenesis, carcinogenesis, and mutagenesis.

[50]  S. Folstein,et al.  Genetics of austim: complex aetiology for a heterogeneous disorder , 2001, Nature Reviews Genetics.

[51]  W. Lipkin,et al.  Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses, and animal models. , 2001, Mental retardation and developmental disabilities research reviews.

[52]  A. Olshan,et al.  GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. , 2001, American journal of epidemiology.

[53]  I. Pogribny,et al.  Homocysteine metabolism in children with Down syndrome: in vitro modulation. , 2001, American journal of human genetics.

[54]  M. Lauritsen,et al.  The genetics of autism , 2001, Acta psychiatrica Scandinavica.

[55]  Freya Q. Schafer,et al.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.

[56]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[57]  H. Blom,et al.  Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. , 2001, QJM : monthly journal of the Association of Physicians.

[58]  N. Bottini,et al.  Autism: evidence of association with adenosine deaminase genetic polymorphism , 2001, Neurogenetics.

[59]  L. Matherly,et al.  Molecular and cellular biology of the human reduced folate carrier. , 2001, Progress in nucleic acid research and molecular biology.

[60]  R. Domínguez,et al.  Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients , 2001, Journal of Neural Transmission.

[61]  W. Dröge,et al.  Glutathione and immune function , 2000, Proceedings of the Nutrition Society.

[62]  B. Leventhal,et al.  The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.

[63]  E. Mosharov,et al.  The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. , 2000, Biochemistry.

[64]  I. Pogribny,et al.  Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA Hypomethylation* , 2000, The Journal of Biological Chemistry.

[65]  P. Klatt,et al.  Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. , 2000, European journal of biochemistry.

[66]  J B Schulz,et al.  Glutathione, oxidative stress and neurodegeneration. , 2000, European journal of biochemistry.

[67]  O. Griffith,et al.  Biologic and pharmacologic regulation of mammalian glutathione synthesis. , 1999, Free radical biology & medicine.

[68]  V. L. Wilson,et al.  Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. , 1999, The American journal of clinical nutrition.

[69]  Kenneth K Kidd,et al.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.

[70]  S. Saw.  Homocysteine and atherosclerotic disease: the epidemiologic evidence. , 1999, Annals of the Academy of Medicine, Singapore.

[71]  J F Gregory,et al.  Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. , 1999, The Journal of nutrition.

[72]  Hall.  The role of glutathione in the regulation of apoptosis , 1999, European journal of clinical investigation.

[73]  Mario Cleves,et al.  Hardy-Weinberg equilibrium test and allele frequency estimation , 1999 .

[74]  B. Seetharam.  Receptor-mediated endocytosis of cobalamin (vitamin B12). , 1999, Annual review of nutrition.

[75]  J. Finkelstein,et al.  The metabolism of homocysteine: pathways and regulation , 1998, European Journal of Pediatrics.

[76]  C. Shaw,et al.  Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death , 1997, Brain Research Reviews.

[77]  P. Grattan-Smith,et al.  The neurological syndrome of infantile cobalamin deficiency: Developmental regression and involuntary movements , 1997, Movement disorders : official journal of the Movement Disorder Society.

[78]  A. Bailey,et al.  Autism as a strongly genetic disorder: evidence from a British twin study , 1995, Psychological Medicine.

[79]  S. Graham,et al.  Long-term neurologic consequences of nutritional vitamin B12 deficiency in infants. , 1992, The Journal of pediatrics.

[80]  J. Finkelstein,et al.  Methionine metabolism in mammals. , 1990, The Journal of nutritional biochemistry.

[81]  A. Meister,et al.  Glutathione is required for intestinal function. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[82]  M M Konstantareas,et al.  Ear infections in autistic and normal children. , 1987, Journal of autism and developmental disorders.

[83]  M. Litt,et al.  Adenosine deaminase activity decreased in autism. , 1982, Journal of the American Academy of Child Psychiatry.

[84]  P. Clayton,et al.  B12 deficiency and psychiatric disorders: case report and literature review. , 1981, Biological psychiatry.